These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24156894)

  • 1. Adjunctive treatment of severe sepsis.
    Dinubile M
    Lancet Infect Dis; 2013 Nov; 13(11):917-8. PubMed ID: 24156894
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.
    Hotchkiss RS; Monneret G; Payen D
    Lancet Infect Dis; 2013 Mar; 13(3):260-8. PubMed ID: 23427891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sepsis-induced immunoparalysis: mechanisms, markers, and treatment options.
    Hamers L; Kox M; Pickkers P
    Minerva Anestesiol; 2015 Apr; 81(4):426-39. PubMed ID: 24878876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of treatments based on the cytokine storm theory of sepsis: time for a novel approach.
    Giamarellos-Bourboulis EJ
    Immunotherapy; 2013 Mar; 5(3):207-9. PubMed ID: 23444949
    [No Abstract]   [Full Text] [Related]  

  • 5. How could we enhance translation of sepsis immunology to inform immunomodulation trials in sepsis?
    Shankar-Hari M
    Crit Care; 2017 May; 21(1):125. PubMed ID: 28571579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomodulation in sepsis: state of the art and future perspective.
    Antonopoulou A; Giamarellos-Bourboulis EJ
    Immunotherapy; 2011 Jan; 3(1):117-28. PubMed ID: 21174562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do circulating cytokines really matter in sepsis?
    Tetta C; Bellomo R; D'Intini V; De Nitti C; Inguaggiato P; Brendolan A; Ronco C
    Kidney Int Suppl; 2003 May; (84):S69-71. PubMed ID: 12694313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating the inflammatory response in sepsis.
    Leitman IM
    J Surg Res; 2011 Dec; 171(2):e183-5. PubMed ID: 21962808
    [No Abstract]   [Full Text] [Related]  

  • 9. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter for sepsis.
    Hirasawa H; Oda S; Nakamura M; Watanabe E; Shiga H; Matsuda K
    Blood Purif; 2012; 34(2):164-70. PubMed ID: 23095416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controversies in neonatal sepsis: immunomodulation in the treatment and prevention of neonatal sepsis.
    Moss SJ; Gennery AR
    Adv Exp Med Biol; 2006; 582():71-83. PubMed ID: 16802620
    [No Abstract]   [Full Text] [Related]  

  • 11. Host-mediated tissue damage.
    Forsyth KD
    J Paediatr Child Health; 1994 Aug; 30(4):296-7. PubMed ID: 7946537
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response and cytokines in septic rats undergoing blood transfusion.
    Salinas JC; Cabezali R; Torcal J; Larrad L; Sousa R; Navarro M; Lozano R
    J Surg Res; 1998 Dec; 80(2):295-9. PubMed ID: 9878327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis.
    Mei SH; Haitsma JJ; Dos Santos CC; Deng Y; Lai PF; Slutsky AS; Liles WC; Stewart DJ
    Am J Respir Crit Care Med; 2010 Oct; 182(8):1047-57. PubMed ID: 20558630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy of sepsis.
    van der Poll T
    Lancet Infect Dis; 2001 Oct; 1(3):165-74. PubMed ID: 11871493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-Series Expression of Toll-Like Receptor 4 Signaling in Septic Mice Treated with Mesenchymal Stem Cells.
    Wu KH; Wu HP; Chao WR; Lo WY; Tseng PC; Lee CJ; Peng CT; Lee MS; Chao YH
    Shock; 2016 Jun; 45(6):634-40. PubMed ID: 26682950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elimination of inflammatory mediators in sepsis by means of sorption detoxification methods].
    Iakubtsevich RE; Spas VV; Shapel' IA; Kuznetsov OE
    Anesteziol Reanimatol; 2008; (6):55-7. PubMed ID: 19230180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood and plasma treatments: the rationale of high-volume hemofiltration.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():387-95. PubMed ID: 17464149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of continuous blood purification on plasma cytokines in children with severe sepsis].
    Yang J; Tian ZF
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Apr; 30(4):921-3. PubMed ID: 20423880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on application of intermittent hemofiltration combined with hemoperfusion in the early stage of severe burn in the prevention and treatment of sepsis].
    Guo W; Lei J; Duan P; Ma X
    Zhonghua Shao Shang Za Zhi; 2015 Aug; 31(4):248-53. PubMed ID: 26715634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-inflammatory cytokine profile of critically ill septic patients following therapeutic plasma exchange.
    Hamishehkar H; Beigmohammadi MT; Abdollahi M; Mousavi S; Ziaie S; Sharifian RA; Davoudi S; Mojtahedzadeh M
    Transfus Apher Sci; 2013 Feb; 48(1):75-8. PubMed ID: 22981045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.